Endocrine resistance in breast cancer: Current status and a perspective on the roles of miRNAs (Review)

被引：16

作者：

Zhou, Jichun ^{[1
]}

Teng, Rongyue ^{[1
]}

Wang, Qinchuan ^{[1
]}

Xu, Chenpu ^{[1
]}

Guo, Jufeng ^{[1
]}

Yuan, Chao ^{[1
]}

Shen, Jianguo ^{[1
]}

Hu, Wenxian ^{[1
]}

Wang, Linbo ^{[1
]}

Xie, Shuduo ^{[1
]}

机构：

[1] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Surg Oncol, Hangzhou 310016, Zhejiang, Peoples R China

来源：

ONCOLOGY LETTERS | 2013年 / 6卷 / 02期

基金：

中国国家自然科学基金;

关键词：

miRNAs; breast cancer; endocrine resistance; ESTROGEN-RECEPTOR-ALPHA; MICRORNA EXPRESSION; POSTMENOPAUSAL WOMEN; GENE-EXPRESSION; TAMOXIFEN RESISTANCE; AROMATASE INHIBITORS; DOWN-REGULATION; TUMOR INVASION; SMALL RNAS; THERAPY;

D O I：

10.3892/ol.2013.1405

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Current endocrine therapies for females with estrogen receptor-positive breast cancer have facilitated substantial improvements in outcomes. The effectiveness of endocrine therapy is limited by either initial de novo resistance or acquired endocrine resistance. Multiple mechanisms responsible for endocrine resistance have been proposed, including deregulation of various components of the estrogen receptor (ER) pathway, alterations in cell cycle and cell survival signaling molecules, and the activation of escape pathways. Dysregulation of miRNA expression has been associated with experimental and clinical endocrine therapy resistance. miRNAs are pivotal to understanding the complex biological mechanism of endocrine resistance, and may serve as novel candidate predictive and prognostic surrogates and therapeutic targets. This review focuses on current progress concerning the roles of miRNAs in endocrine resistance, and discusses the challenges and opportunities for implementing miRNA-based assays and treatment for patients with endocrine-resistant breast cancer.

引用

页码：295 / 305

页数：11

共 50 条

[21] Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA
Hayes, Erin L.
Lewis-Wambi, Joan S.
[J]. BREAST CANCER RESEARCH, 2015, 17
[22] Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA
Erin L Hayes
Joan S Lewis-Wambi
[J]. Breast Cancer Research, 17
[23] Endocrine resistance in advanced breast cancer: current evidence and future directions
Barrios, Carlos H.
Fay, Andre P.
Debiasi, Marcio
Werutsky, Gustavo
[J]. BREAST CANCER MANAGEMENT, 2012, 1 (04) : 305 - 314
[24] Review of the current status of magnetic resonance in breast cancer
Fernandez Cuadriello, E.
[J]. CLINICA E INVESTIGACION EN GINECOLOGIA Y OBSTETRICIA, 2018, 45 (02): : 69 - 77
[25] The roles of oncogenic miRNAs and their therapeutic importance in breast cancer
O'Bryan, Samia
Dong, Shengli
Mathis, J. Michael
Alahari, Suresh K.
[J]. EUROPEAN JOURNAL OF CANCER, 2017, 72 : 1 - 11
[26] miRNAs in breast cancer tumorigenesis (Review)
Zhang, Zhong Ju
Ma, Shi Liang
[J]. ONCOLOGY REPORTS, 2012, 27 (04) : 903 - 910
[27] CURRENT STATUS OF ENDOCRINE TREATMENT OF CARCINOMA OF THE BREAST
BUZDAR, AU
[J]. SEMINARS IN SURGICAL ONCOLOGY, 1990, 6 (02): : 77 - 82
[28] Current status of adjuvant endocrine therapy for premenopausal patients with primary breast cancer
A Howell
[J]. Breast Cancer Research, 9
[29] Extended Adjuvant Endocrine Therapy in Breast Cancer: Current Status and Future Directions
Goss, Paul E.
Muss, Hyman B.
Ingle, James N.
Whelan, Timothy J.
Wu, Melinda
[J]. CLINICAL BREAST CANCER, 2008, 8 (05) : 411 - 417
[30] Current status of adjuvant endocrine therapy for premenopausal patients with primary breast cancer
Howell, A.
[J]. BREAST CANCER RESEARCH, 2007, 9 (01)

← 1 2 3 4 5 →